Potential Drug-Related Problems in Ischemic Stroke Patients and Their Effect on Clinical Outcomes at RS X, East Jakarta, in 2019

Delina Hasan, Muhammad Yanis Musdja, Harini Nastiti Hajri

Abstract

Background, Stroke is a circulatory disorder of the brain caused by narrowing of blood vessels due to comorbidities such as hypertension and hyperlipidemia. Thus, causing functional disorders of the brain in the form of neurological deficits/nerve paralysis for 24 hours or more. Treatment of stroke with comorbidities will result in Drug Related Problem (DRP). The purpose of this study was to determine DRPs and their effects on clinical outcomes in  ischemic stroke patients at RS X East Jakarta in 2019. Methodology, This study uses a cross-sectional design, and data collection was carried out retrospectively on 120 medical records of ischemic stroke patients in 2018. The data obtained were analyzed with SPSS, for drug interactions based on literature and observations of prescriptions for ischemic stroke patients, The results of the study found 36.07% drug interactions, 29.51% indications without drugs, 9.29% drugs without indications, 6.56% frequency of administration exceeding the rules of use, 5.46% doses too high, 4.37% frequency of administration less than the rules of use, 2.73% doses too low, 2.19% too many drugs for the same indications, 1.64% of each drug did not comply with treatment guidelines, inappropriate drugs due to contraindications, and 0.55% inappropriate duplication of active substance. There was an association between DRP and patient clinical outcomes but not significant. Recommendation, Better collaboration among doctors, pharmacists, and other health workers is needed to obtain safe and effective treatment outcomes.

 

Keywords: clinical outcome, drug-related problem, ischemic stroke.

 

https://doi.org/10.55463/issn.1674-2974.50.8.8


Full Text:

PDF


References


GUSTAVIANI R. Diagnosis dan Klasifikasi Diagnosis and Klasifikasi Diabetes Mellitus. In: ARU W. S., BAMBANG S., IDRUS A., MARCELLUS S. K., and SITI S. (eds.) Buku Ajar Ilmu Penyakit Dalam. Jakarta. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia, 2007: 1857–1859.

WHO. Top Ten Causes of Death. World Health Organisation, 2018. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

DINATA C. A., SAFRITA Y., and SASTRI S. Gambaran Faktor Risiko dan Tipe Stroke pada Pasien Rawat Inap di Bagian Penyakit Dalam RSUD Kabupaten Solok Selatan Periode 1 Januari 2010 - 31 Juni 2012. Jurnal Kesehatan Andalas, 2013, 2: 57–61. https://doi.org/10.25077/jka.v2i2.119

CIPOLLE R., STRAND L., and MORLEY P. Pharmaceutical Care Practice. McGraw-Hill Companies Inc, New York, 2012.

WINDARTHA I. P. Identifikasi Potensi Drug Related Problems (DRPs) Pada Pasien Stroke Non Hemoragik di RSD dr. Soebandi Jember. Artikel Ilmiah Hasil Penelitian Mahasiswa 2013, 2012. https://repository.unej.ac.id/bitstream/handle/123456789/61848/Iwan%20Permana%20Windartha.pdf?sequence=1&isAllowed=y

CELIN A. T., SEUMA J., and RAMESH A. Assessment of drug-related problems in stroke patients admitted to a South Indian Tertiary Care Teaching Hospital. Indian Journal of Pharmacy Practice, 2012, 5: 28–33. https://jpc.tums.ac.ir/index.php/jpc/article/view/49

VIKTIL K. K., & BLIX H. S. Impact of Clinical Pharmacists on Drug-Related Problems and Clinical Outcomes. Journal compilation Nordic Pharmacological Society Basic & Clinical Pharmacology & Toxicology, 2008, 102: 275–280. https://doi.org/10.1111/j.1742-7843.2007.00206.x

BHASKAR S. Clinics in Surgery Glasgow Coma Scale : Technique and Intepretation. Clinics in Surgery, 2017; 2: 2–5. https://www.clinicsinsurgery.com/open-access/glasgow-coma-scale-technique-and-intepretation-3009.pdf

JAMES P. A., OPARIL S., CARTER B. L., CUSHMAN W. C., DENNISON-HIMMELFARB C., HANDLER J., LACKLAND D. T., LEFEVRE M. L., MACKENZIE T. D., OGEDEGBE O., SMITH S. C., SVETKEY L. P., TALER S. J., TOWNSEND R. R., WRIGHT J. T., NARVA A. S., and ORTIZ E. Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 2014, 311(5): 507–520. https://doi.org/10.1001/jama.2013.284427

KABI G., TUMEWAH R., and KEMBUAN M. Gambaran Faktor Risiko Pada Penderita Stroke Iskemik Yang Dirawat Inap Neurologi Rsup Prof. Dr. R. D. Kandou Manado Periode Juli 2012 - Juni 2013. e-CliniC, 2015, 3(1). https://doi.org/10.35790/ecl.3.1.2015.7404

MUHRINI A., SIHOMBING I. Y., and HAMRA Y. Hubungan Umur, Jenis Kelamin, and Hipertensi dengan Kejadian Stroke. Jurnal Medula, 2013, 1: 24–30. https://dx.doi.org/10.33772/medula.v1i1.182

BUSHNELL C. D., JOHNSTON D. C. C., and GOLDSTEIN L. B. Comparison of the NIH Stroke Scale and Canadian Neurological Scale. Stroke, 2001, 32: 656–660. https://doi.org/10.1161/01.str.32.3.656

WATILA M. M., NYANDAITI Y. W., BWALA S. A., and IBRAHIM A. Gender Variation in Risk Factors and Clinical Presentation of Acute Stroke, Northeastern Nigeria. Journal of Neuroscience and Behavioural Health, 2011, 3(3): 38–43. https://academicjournals.org/article/article1379672092_Watila%20et%20al.pdf

LAILY S. R. Hubungan karakteristik penderita dan hipertensi dengan kejadian stroke iskemik. Jurnal Berkala Epidemiologi, 2017, 5: 48–59. https://e-journal.unair.ac.id/JBE/article/download/3142/2811

NESS J., ARONOW W. S., and AHN C. Risk Factors for Ischemic Stroke in Older Persons in an Academic Hospital-Based Geriatrics Practice. Preventive Cardiology, 2000, 3: 118–120. https://doi.org/10.1111/j.1520-037x.2000.80372.x

JUNAIDI I. Stroke, Waspadai Ancamannya. Andi, Yogyakarta, 2011.

HARRIGAN M., & DEVEIKIS J. Acute Ischemic Stroke. In: HARRIGAN M. R., & DEVEIKIS J. P. Handbook of Cerebrovascular Disease & Neurointerventional Technique. Humana Press, New York, 2009: 571–605. https://doi.org/10.1007/978-3-319-66779-9

MANSOUR O. Y. Acute ischemic stroke prognostication and comparison between Glasgow Coma Score, NIHS Scale, and Full Outline of Unresponsiveness Score in the intensive care unit. Alexandria Journal of Medicine, 2015, 51: 247–253. https://doi.org/10.1016/j.ajme.2014.10.002

TIEKO L., & KUSANO E. Diagnosis and control of polypharmacy in the elderly. Saúde Pública, 2007, 41 (6): 1049–1053. https://doi.org/10.1590/S0034-89102006005000050

RESLINA I., ALMASDY D., and ARMENIA A. Hubungan Pengobatan Stroke dengan Jenis Stroke dan Jumlah Jenis Obat. Jurnal Ipteks Terapan, 2015, 9: 69–77. http://dx.doi.org/10.22216/jit.2015.v9i1.29

RIZALDY T., & YEMIMA H. Apakah Pemberian Sitikolin Dapat Mencegah Luaran Klinis Buruk Pada Pasien Stroke? Jurnal Farmaka Yogyakarta, 2017, 15: 68–79. https://doi.org/10.24198/jf.v15i4.13736

MARTONO H., & KUSWANDANI R. Ilmu Penyakit Dalam. Interna Publishing, Jakarta, 2009.

TALBERT R. Cardiovascular: Dislipidemia in DiPiro JT et al. Pharmacotherapy: 10th Edition. New York, McGraw-Hill Companies, 2017.

FAGAN S., & HESS D. Cardiovascular: Dislipidemia in DiPiro JT et al. Pharmacotherapy. 10th ed. New York, McGraw-Hill Companies, 2017.

GARIBALLA S. E., ROBINSON T. G., and FOTHERBY M. D. Hypokalemia and Potassium Excretion in Stroke Patients. The American Geriatrics Society, 1997, 45: 1454–1458. https://doi.org/10.1111/j.1532-5415.1997.tb03195.x

SIDDIQUI M. R., ISLAM Q. T., HAQUE A., IQBAL J., HOSSAIN A., RAHMAN Y. U., MAHBUB M. S., and SAZZAD A. A. Electrolyte Status in Different Types of Acute Stroke Patients and Their Correlation with Some Common Clinical Presentation. Journal of Medicine, 2012, 13: 133–137. https://www.banglajol.info/index.php/JOM/article/view/12740/9184

Powers W. J., Rabinstein A. A., Ackerson T., Adeoye O. M., Bambakidis N. C., Becker K., Biller J., Brown M., Demaerschalk B. M., Hoh B., Jauch E. C., Kidwell C. S., Leslie-Mazwi T. M., Ovbiagele B., Scott P. A., Sheth K. N., Southerland A. M., Summers D. V., and Tirschwell D. L. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 2018, 49(3): 46-99. https://doi.org/10.1161/STR.0000000000000158

LANDEFELD K., GONZALES H., and SANDER G. E. Journal of Clinical Case Reports Hypertensive Crisis : Causative Effects of Nonsteroidal Anti-Inflammatory Drugs. Journal of Clinical Case Reports, 2016, 6: 9–11. https://doi.org/10.4172/2165-7920.1000838[29] DAVIS S. N. Role of glimepiride in the effective management of type 2 diabetes. Journal of Diabetes and Its Complications, 2004, 18: 367–376. https://doi.org/10.1517/17425250903512955

AMERICAN HEART ASSOSIATION. How Potassium Can Help Control High Blood Pressure. American Heart Association, 2016. https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/how-potassium-can-help-control-high-blood-pressure

MAYO CLINIC STAFF. Statins: Are these cholesterol-lowering drugs right for you? Mayo Clinic, 2018. https://www.mayoclinic.org/ diseases-conditions/high-blood-cholesterol/in-depth/statins/art-20045772

KEMENTERIAN KESEHATAN RI FARMALKES. Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotik. Kementerian Kesehatan RI Farmalkes, 2020. https://farmalkes.kemkes.go.id/unduh/pedoman-pelayanan-kefarmasian-untuk-terapi-antibiotik/

PERHIMPUNAN DOKTER SPESIALIS KARDIOVASKULAR INDONESIA. Pedoman Tatalaksana Dislipidemia. Jakarta, Centra Communications, 2013.

GILROY J. Basic Neurology. New York, McGraw-Hill Education Companies, 2000.

MACDONALD J. E., & STRUTHERS A. D. What Is the Optimal Serum Potassium Level in Cardiovascular Patients ? Journal of the American College of Cardiology, 2004, 43: 155–161. https://doi.org/10.1016/j.jacc.2003.06.021

LAKHAN S. E., KIRCHGESSNER A., and HOFER M. Inflammatory mechanisms in ischemic stroke : therapeutic approaches. Journal of Translational Medicine, 2009, 7: 97. https://doi.org/10.1186/1479-5876-7-97

GOFIR A., & INDERA I. Hitung Angka Lekosit Sebagai Salah Satu Prediktor Prognosis Functional Outcome dan Lama Perawatan Rumah Sakit Pada Stroke Iskemik Akut. Media Litbangkes, 2014, 24: 67–74. https://dx.doi.org/10.22435/mpk.v24i2.3563.67-74

STANFORD HEALTH CARE. Therapeutic Duplication. Stanford Health Care, 2016. https://stanfordhealthcare.org/content/dam/SHC/health-care-professionals/medical-staff/medstaff-weekly/20161102-therapeutic-duplication.pdf

TURAN B., DEMIR H., MUTLU A., DAŞLI T., ERKOL A., and ERDEN İ. Inappropriate combination of warfarin and aspirin. The Anatorian Journal of Cardiology, 2016, 16: 189–196. https://doi.org/10.5152/akd.2015.6050

BHATT D. L., FOX K. A. A., HACKE W., BERGER P. B., BLACK H. R., BODEN W. E., CACOUB P., COHEN E. A., CREAGER M. A., EASTON J. D., FLATHER M. D., HAFFNER S. M., HAMM C. W., HANKEY G. J., JOHNSTON S. C., MAK K.-H., MAS J.-L., MONTALESCOT G., PEARSON T. A., STEG P. G., STEINHUBL S. R., WEBER M. A., BRENNAN D. M., FABRY-RIBAUDO L., BOOTH J., and TOPOL E. J. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. The New England Journal of Medicine, 2006, 354: 1706–1717. https://doi.org/10.1056/nejmoa060989

ASLAM, M. Farmasi Klinis (Clinical Pharmacy) Menuju Pengobatan Rasional dan Penghargaan Pilihan Pasien. Jakarta, PT Elex Media Komputindo Gramedia, 2003. http://katalog.pustaka.unand.ac.id//index.php?p=show_detail&id=109287

GOTTWALD-HOSTALEK U., LI L., and MONTENEGRO P. Bisoprolol/Amlodipine Combination Therapy Improves Blood Pressure Control in Patients with Essential Hypertension Following Monotherapy Failure. Current Medical Research and Opinion, 2016, 32: 1735–1743. https://doi.org/10.1080/03007995.2016.1205573

LEXICOMP. Drug Information Handbook with International Trade Names Indeks 23rd Edition. Ohio, Lexicomp, 2014. https://books.google.ru/books/about/Drug_Information_Handbook.html?id=VdYHngEACAAJ&redir_esc=y

DRUGS. Drug Interactions Checker. Drugs, 2023. drugs.com/drug_interactions.html

SERBIN M. A. Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis. Journal of Managed Care & Specialty Pharmacy, 2016, 22: 939–947. https://doi.org/10.18553/jmcp.2016.22.8.939

GUERRERO-ROMERO F., & RODRI M. Proteinuria is an Independent Risk Factor for Ischemic Stroke in Non -insulin-dependent Diabetes Mellitus. Stroke, 1999, 30: 1787–1791. https://doi.org/10.1177%2F1747493019895206

WINNICKA K., TOMASIAK M., and BIELAWSKA A. Piracetam - an Old Drug with Novel Properties? Acta Poloniae Pharmaceutica - Drug Research, 2005, 62: 405–409. https://pubmed.ncbi.nlm.nih.gov/16459490/

DIREKTORAT JENDERAL KEFARMASIAN DAN ALAT KESEHATAN. Modul 1 Materi Pelatihan Peningkatan Pengetahuan Dan Keterampilan Memilih Obat Bagi Tenaga Kesehatan. Jakarta, Departemen Kesehatan Republik Indonesia, 2008. http://perpustakaan.bkpk.kemkes.go.id/index.php?p=show_detail&id=38982

GINSBERG M. D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology, 2008, 55: 363–389. https://doi.org/10.1016/j.neuropharm.2007.12.007


Refbacks

  • There are currently no refbacks.